Dr Thomas Ramdahl Joins Clarity Pharmaceuticals’ Board
Sydney, Australia 26 March 2019 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is delighted to announce that Dr Thomas Ramdahl will join Clarity’s Board. Dr Ramdahl is a pharmaceutical executive with more than 20 years of clinical and development experience. In 2001, he became President and the first CEO of…